C. diff. Spores and More

Join Your Host, Nancy Caralla, with Guest Host Kevin Hersh as they discuss proven ways to prevent the FLU virus and more.

This special episode with Host Nancy Caralla and Guest Host Kevin Hersh turn up the volume with C. diff. Survivors Jennifer W. and Robin S. as they share their journey through a C. diff. infection.

Join us with our guests: Caitlin Stowe is a master’s prepared infection preventionist currently employed with PDI as the Clinical Affairs Research Manager and

Megha Patel is a Senior Product Manager with PDI, focused on new product development. Both professionals will be discussing innovation in

C. difficile prevention.

Join us with guest, L. Clifford McDonald, MD.

Dr. McDonald, MD graduated from Northwestern University Medical School. He completed a medical microbiology fellowship at Duke University and is a former member of CDC’s Epidemic Intelligence Service. Dr. McDonald is currently the Associate Director for Science in the Division of Healthcare Quality Promotion at the CDC. He has first-authored or co-authored over 100 peer-reviewed publications on subjects related to healthcare and infectious disease epidemiology.

Listen in as Dr. McDonald discusses the Centers for Disease Control and Prevention (CDC) newly released report; 2019 Antibiotic Resistance Threats in the United States and what that means in the C. difficile community.

Join us with our guest: Maureen Spencer, RN, M.Ed., CIC joining us to discuss an array of important topics:

1. Overuse and inappropriate prescribing of antibiotics worldwide is leading to the global healthcare issue of antibiotic resistance. 2. Empiric antibiotics are used consistently in healthcare when infection is suspected

3. Empiric antibiotics are prescribed to cover gram positive, gram negative and yeast infections until the final lab result is available 4. Overuse of antibiotics adversely effect the normal flora and microbiome in the body depleting colonies of bacteria that are necessary for digestion and protection. 5. When the microbiome is depleted other resistant species overgrow on the skin and in the systems of the body, especially the gut. 6. Multiple Drug Resistant organisms MDRO include MRSA, VRE, ESBL and CRE that will grow in patients who have been on antibiotics AND MUCH MORE.

This special episode with Host Nancy Caralla and Guest Host Kevin Hersh turn up the volume with C. diff. Survivors Jennifer W. and Robin S. as they share their journey through a C. diff. infection.

Join Us with guest: Karl Kappeler, MS, RPh, FASHP

Director, Medical Affairs of Azurity Pharmaceuticals.

and will be discussing C. difficile infections, C. diff. treatment options and the Azurity Pharmaceuticals organization with its FDA approved product.

Listen in as we learn more about the Company’s history, their unique product offerings that help pharmacists

compound drugs, and product information for FIRVANQ, their FDA approved vancomycin

oral solution.

Join Our Guests: Kerrie Davies, Principal Clinical Scientist, and Visiting Research Fellow, Leeds Teaching Hospitals NHS Trust and the University of Leeds, and Dr. Jane Freeman, Clinical Scientist and Visiting Research Fellow, Leeds Teaching Hospitals NHS Trust and the University of Leeds. HEE/NIHR ICA Clinical Lecturer as they discuss Antimicrobial Resistance.--the who, what, how, and why of AMR and the importance of this topic. You won't want to miss this episode -Antibiotic Resistance is everyone's business!

Join us with guest, L. Clifford McDonald, MD.

Dr. McDonald, MD graduated from Northwestern University Medical School. He completed a medical microbiology fellowship at Duke University and is a former member of CDC’s Epidemic Intelligence Service. Dr. McDonald is currently the Associate Director for Science in the Division of Healthcare Quality Promotion at the CDC. He has first-authored or co-authored over 100 peer-reviewed publications on subjects related to healthcare and infectious disease epidemiology.

Listen in as Dr. McDonald discusses the Centers for Disease Control and Prevention (CDC) newly released report; 2019 Antibiotic Resistance Threats in the United States and what that means in the C. difficile community.

Join us and learn from our guests;

Dr. Clifford McDonald, MD, Senior Advisor for Science and Integrity, Division of Healthcare Quality Promotion at the CDC with main interests in epidemiology and prevention of Healthcare-Associated Infections, especially Clostridium difficile infections, and the prevention of antimicrobial resistance. And

Dr. Arjun Srinivasan, MD, Associate Director for Healthcare-Associated Infection prevention programs in the Division of Healthcare Quality Promotion at CDC's National Center for Emerging and Zoonotic Infectious Disease. Listen in as these two stellar Physicians discuss the topics of Clostridium difficile infections and Antibiotic usage, two important issues with potential solutions facing the citizens on a global level..